Principal Investigator
Alan Libardi Dal Pra
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20251027
Clinical Trial Summary
The Phase III Adaptive Radiation and Chemotherapy for Muscle Invasive Bladder Cancer Trial (ARCHER)
Phase
Phase III
Funding Agency/Sponsor
National Cooperative Group
Disease
Prostate, Bladder, and Kidney Cancers
Contact Information
Phone Number
+1 (305) 2439731